Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Acute Myeloid Leukemia and Myelodysplasia Related Changes: Trends in Survival between 2000 and 2013

Yazhini Vallatharasu, MD, Dipesh Uprety, MD, Amir Bista, MD

Blood (2017) 130 (Supplement 1): 3863.

https://doi.org/10.1182/blood.V130.Suppl_1.3863.3863

Published: 2017

Journal Articles

Impact of Socioeconomic, Demographic and Health System Factors on Therapy in Acute Myeloid Leukemia

Gaurav Goyal, MBBS, Lata Nawal, MPH, Kailash Mosalpuria, MD MPH, Peter T. Silberstein, MD

Blood (2015) 126 (23): 3316.

https://doi.org/10.1182/blood.V126.23.3316.3316

Published: 2015

Journal Articles

Alloimmune Effect May Improve Survival of De Novo Myelodysplastic Syndrome After allogeneic hematopoietic cell transplantaion: A Single Center Analysis of 115 Patients

Nobuhiro Hiramoto, MD, Kinuko Tajima, Saiko Kurosawa, MD, Takuya Yamashita, MD, Kenji Okinaka, MD, Noriyuki Morikawa, MD, Kohei Tada, MD, Takashi Tanaka, MD, Ryosuke Ueda, MD, Yujin Kobayashi, MD, Akihito Shinohara, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Yuji Heike, MD, Takahiro Fukuda, MD

Blood (2011) 118 (21): 2033.

https://doi.org/10.1182/blood.V118.21.2033.2033

Published: 2011

Journal Articles

Establishment and Characterization of a Novel Human Myeloid Leukemia Cell Line, AMU-AML1, Carrying t(12;22)(p13;q11) with No Fusion of MN1-TEL

Mayuko Goto, MD, Ichiro Hanamura, MD, PhD, Motohiro Wakabayashi, MD, PhD, Hisao Nagoshi, MD, Tomohiko Taki, MD, PhD, Norikazu Imai, MD, PhD, Mineo Goto, MD, Shohei Mizuno, MD, Miyuki Takahashi, MD, Kazuto Suganuma, MD, Akihito Hiramatsu, MD, PhD, Hidesuke Yamamoto, MD, PhD, Masaya Watarai, MD, PhD, Masato Shikami, MD, PhD, Akira Imamura, MD, PhD, Hidetsugu Mihara, MD, PhD, Masafumi Taniwaki, MD, PhD, Hiroshi Miwa, MD, PhD, Masakazu Nitta, MD, PhD

Blood (2010) 116 (21): 4375.

https://doi.org/10.1182/blood.V116.21.4375.4375

Published: 2010

Journal Articles

The Genotype Consisting of Complex Karyotype and TP53 Gene Mutation Is Specific to Acute Myeloid Leukemia with Multilineage Dysplasia

Yuichi Ishikawa, M.D., Hitoshi Kiyoi, M.D.Ph.D, Akane Tsujimura, MD, Yasushi Miyazaki, M.D.Ph.D, Masao Tomonaga, M.D.Ph.D, Kazutaka Kuriyama, M.D.Ph.D, Shuichi Miyawaki, M.D.Ph.D, Tomoki Naoe, M.D.Ph.D

Blood (2008) 112 (11): 2507.

https://doi.org/10.1182/blood.V112.11.2507.2507

Published: 2008

Journal Articles

Gene Expression Profiling of Acute Myeloid Leukemia with Multilineage Dysplasia (AML-MD) Reveals a Biological Diversity Related to Underlying Cytogenetics but Also Identifies a Distinctive Profile in Normal Karyotype AML-MD.

María Rozman, MD, Susana G. Kalko, PhD, Jordi Esteve, MD, Mireia Camós, MD, Josep-Lluís Aguilar, MD, Montserrat Torrebadell, MD, Dolors Costa, PhD, Ana Carrió, PhD, Pedro Jares, PhD, Emili Montserrat, MD, Elías Campo, MD

Blood (2006) 108 (11): 2244.

https://doi.org/10.1182/blood.V108.11.2244.2244

Published: 2006

Journal Articles

Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning

Aloysius Y. L. Ho, Antonio Pagliuca, Michelle Kenyon, Jane E. Parker, Aleksandar Mijovic, Stephen Devereux, Ghulam J. Mufti

Blood (2004) 104 (6): 1616–1623.

https://doi.org/10.1182/blood-2003-12-4207

Published: 2004

NARROW

Acute Myeloid Leukemia and Myelodysplasia Related Changes: Trends in Survival between 2000 and 2013

Impact of Socioeconomic, Demographic and Health System Factors on Therapy in Acute Myeloid Leukemia

Alloimmune Effect May Improve Survival of De Novo Myelodysplastic Syndrome After allogeneic hematopoietic cell transplantaion: A Single Center Analysis of 115 Patients

Establishment and Characterization of a Novel Human Myeloid Leukemia Cell Line, AMU-AML1, Carrying t(12;22)(p13;q11) with No Fusion of MN1-TEL

The Genotype Consisting of Complex Karyotype and TP53 Gene Mutation Is Specific to Acute Myeloid Leukemia with Multilineage Dysplasia

Gene Expression Profiling of Acute Myeloid Leukemia with Multilineage Dysplasia (AML-MD) Reveals a Biological Diversity Related to Underlying Cytogenetics but Also Identifies a Distinctive Profile in Normal Karyotype AML-MD.

Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning

Email alerts

ASH Publications

American Society of Hematology

Acute Myeloid Leukemia and Myelodysplasia Related Changes: Trends in Survival between 2000 and 2013

Impact of Socioeconomic, Demographic and Health System Factors on Therapy in Acute Myeloid Leukemia

Alloimmune Effect May Improve Survival of De Novo Myelodysplastic Syndrome After allogeneic hematopoietic cell transplantaion: A Single Center Analysis of 115 Patients

Establishment and Characterization of a Novel Human Myeloid Leukemia Cell Line, AMU-AML1, Carrying t(12;22)(p13;q11) with No Fusion of MN1-TEL

The Genotype Consisting of Complex Karyotype and TP53 Gene Mutation Is Specific to Acute Myeloid Leukemia with Multilineage Dysplasia

Gene Expression Profiling of Acute Myeloid Leukemia with Multilineage Dysplasia (AML-MD) Reveals a Biological Diversity Related to Underlying Cytogenetics but Also Identifies a Distinctive Profile in Normal Karyotype AML-MD.

Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only